跳至主要内容
临床试验/NCT07522736
NCT07522736招募中不适用

The Analgesic Effect of Intrathecal Dexmedetomidine With Bupivacaine, in Patients Undergoing Knee Orthopedic Surgery: A Randomized Double-Blinded Dose-Finding Trial

Cairo University1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2025年3月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
入组人数
120
试验地点
1
主要终点
Time to request rescue analgesia

研究概览

简要总结

This study aims to compare the duration of analgesia (as the primary outcome) and adverse effects (as the secondary outcome) after intrathecal administration of dexmedetomidine with hyperbaric bupivacaine to patients undergoing knee orthopedic surgery.

详细描述

Intrathecal adjuncts are commonly added to local anesthetic agents, to improve the duration of nerve blocks and postoperative pain relief without increasing the dosage of local anesthetic.

Studies have shown that dexmedetomidine (DEX) has a greater potential for enhancing analgesic effects due to its higher specificity for alpha2 adrenoceptors. DEX is commonly used for sedation and as an adjunct to reduce the amount of anesthesia and opioids required during general and regional anesthesia in both adults and children.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age from 18 to 65 years.
  • American Society of Anesthesiologists (ASA) physical status I-II.
  • Male patients scheduled for knee orthopedic surgery.

排除标准

  • Patients with psychiatric disorders.
  • History of drug addiction.
  • Contraindication for regional anesthesia.
  • History of hypersensitivity to the study drugs.
  • Previous administration of opioids and/or other central nervous system depressants during current hospital admission.

研究组 & 干预措施

Group I

Experimental

Patients will receive intrathecal hyperbaric bupivacaine 15 mg, supplemented with dexmedetomidine 4 μg.

干预措施: Dexmedetomidine 4 μg (Drug)

Group II

Experimental

Patients will receive intrathecal hyperbaric bupivacaine 15 mg, supplemented with dexmedetomidine 8 μg.

干预措施: Dexmedetomidine 8 μg (Drug)

Group III

Experimental

Patients will receive intrathecal hyperbaric bupivacaine 15 mg, supplemented with dexmedetomidine 12 μg.

干预措施: Dexmedetomidine 12 μg (Drug)

结局指标

主要结局

Time to request rescue analgesia

时间窗: 24 hours postoperatively

Time to request rescue analgesia will be recorded from the end of surgery to the first dose of morphine administrated

次要结局

  • Heart rate(In the recovery room (Up to 2 hours))
  • Mean arterial blood pressure(In the recovery room (Up to 2 hours))
  • Respiratory rate(In the recovery room (Up to 2 hours))
  • Oxygen saturation(In the recovery room (Up to 2 hours))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Abdou Ali Ismail

Assistant Lecturer of Anaesthesia, Surgical ICU, and Pain, Cairo University, Cairo, Egypt.

Cairo University

研究点 (1)

Loading locations...

相似试验